Lack of skilled workers holding back India's biomanufacturing sector
Biomanufacturing in India is being held back by a lack of skilled workers but training initiatives are helping to address the problem, say Oncobiologics and Biocon.
Biomanufacturing in India is being held back by a lack of skilled workers but training initiatives are helping to address the problem, say Oncobiologics and Biocon.
Repligen has added the “gold standard” of fermentation cell retention technology to its portfolio, and says it will develop it further to support the rise in single-use.
Janssen has licensed the LADD immunotherapy platform and GVAX cell-line technology from Aduro BioTech in order to develop combination therapies for a number of prostate cancer candidates.
Update
US states continue to form disparate views of how to deal with biosimilars as Delaware Governor Jack Markell (D) signed into law last week a bill that would require pharmacists to notify prescribers if a biosimilar is substituted for a biologic.